Insider Selling: CME Group CEO Sells 49,000 Shares of Stock (CME)
CME Group (NYSE:CME) CEO Phupinder Gill unloaded 49,000 shares of the company’s stock on the open market in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $71.66, for a total transaction of $3,511,340.00. Following the transaction, the chief executive officer now directly owns 117,101 shares of the company’s stock, valued at approximately $8,391,458. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Shares of CME Group (NYSE:CME) traded down 1.33% during mid-day trading on Tuesday, hitting $70.99. 1,539,314 shares of the company’s stock traded hands. CME Group has a one year low of $66.44 and a one year high of $84.71. The stock has a 50-day moving average of $70.19 and a 200-day moving average of $75.06. The company has a market cap of $23.838 billion and a P/E ratio of 23.98.
CME Group (NYSE:CME) last released its earnings data on Thursday, May 1st. The company reported $0.83 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.83. The company had revenue of $777.00 million for the quarter, compared to the consensus estimate of $368.13 million. During the same quarter in the prior year, the company posted $0.73 earnings per share. The company’s quarterly revenue was up 8.1% on a year-over-year basis. Analysts expect that CME Group will post $3.38 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Wednesday, June 25th. Investors of record on Tuesday, June 10th will be given a dividend of $0.47 per share. This represents a $1.88 dividend on an annualized basis and a yield of 2.65%. The ex-dividend date of this dividend is Friday, June 6th.
A number of research firms have recently commented on CME. Analysts at Jefferies Group reiterated a “buy” rating on shares of CME Group in a research note on Friday, May 9th. They now have a $84.00 price target on the stock, down previously from $89.00. Separately, analysts at JPMorgan Chase & Co. reiterated a “hold” rating on shares of CME Group in a research note on Tuesday, May 6th. They now have a $69.50 price target on the stock, down previously from $76.50. Finally, analysts at Barclays reiterated an “equal weight” rating on shares of CME Group in a research note on Friday, May 2nd. They now have a $78.00 price target on the stock. Eight analysts have rated the stock with a hold rating and eight have given a buy rating to the company. CME Group currently has a consensus rating of “Buy” and an average price target of $73.23.
CME Group Inc (NYSE:CME) offer a range of global products across all asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.